FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely to the use of a compound for the treatment of itch, where the compound is an agonist selective relatively to α2- and/or α3-GABAA-receptors, which provides any of following compounds: 
or 
The invention also relates to a method for the treatment of itch with the above-mentioned compounds.
EFFECT: provision of the treatment of itch with an agonist selective relatively to α2- and/or α3-GABAA-receptors, having the above-mentioned structures.
14 cl, 10 ex, 17 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DESTROYERS | 2017 |
|
RU2797244C2 |
| PYRAZOLOPYRIDINES AND ANALOGUES THEREOF | 2004 |
|
RU2426734C2 |
| 2,6,9-TRISUBSTITUTED PURINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE CATIONIC SALT, METHOD FOR INHIBITION OF CELL PROLIFERATION, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2220968C2 |
| NEW DRUG FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS AND FIBROSIS | 2017 |
|
RU2762280C2 |
| NOVEL COMPOUNDS AND USE THEREOF IN THERAPY | 2004 |
|
RU2412190C2 |
| ESTROGEN RECEPTOR PROTEOLYSIS MODULATORS AND RELATED USES THEREOF | 2018 |
|
RU2797808C2 |
| ACIDYLATED HETEROARYLCONDENSED CYCLOALKENYLAMINES AND THEIR USE AS PHARMACEUTICAL AGENTS | 2003 |
|
RU2338743C2 |
| ACIDIFIED ARYLCYCLOALKYLAMINS AND THEIR APPLICATION AS PHARMACEUTICAL DRUGS | 2003 |
|
RU2337094C2 |
| METHODS FOR INCREASING STABILISATION OF HYPOXYA INDUCED FACTOR-1 ALPHA | 2010 |
|
RU2521251C2 |
| COMBINATION OF HISTONE DEACETYLASE INHIBITORS AND RADIATION | 2006 |
|
RU2436572C2 |
